Clarithromycin Resistant Tailored Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

924

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Peptic UlcerHelicobacter Pylori Infection
Interventions
PROCEDURE

23S rRNA point mutation test of Helicobacter pylori

mutation test group\>\> Helicobacter pylori polymerase chain reaction kit by dual-priming oligonucleotide-based multiplex polymerase chain reaction system before eradication of Helicobacter pylori at mutation test groupConventional Conventional AOC group, Conventional AOM group \>\> no intervention

PROCEDURE

UBT test & Gastroenterology with biopsy c silver stain

UBT test \& Gastroenterology with biopsy c silver stain due to indentify H. pylori infection Conventional AOM group, Conventional AOC group, Mutation test group \>\> intervention

Trial Locations (1)

150-713

Gastroenterology Clinic, Seoul

All Listed Sponsors
collaborator

Korean College of Helicobacter and Upper Gastrointestinal Research

OTHER

lead

Jin Il Kim

OTHER

NCT01453036 - Clarithromycin Resistant Tailored Therapy | Biotech Hunter | Biotech Hunter